EASL SLD 2025 23 - 25 January 2025

Addressing MASH as a liver manifestation of the metabolic disease

Summary
Friday, 24 January 2025
12:30 - 12:32
(WET)

Welcome and introduction

Lise Lotte Gluud
12:32 - 12:50
(WET)

Pathophysiological analysis of MASH: targeting clinical manifestations

Lise Lotte Gluud
12:50 - 13:10
(WET)

Approaching MASH as a metabolic disease with a need for foundational therapy

Mary Rinella
13:10 - 13:25
(WET)

Panel discussion

Lise Lotte Gluud, Mary Rinella
13:25 - 13:30
(WET)

Summary and closing

Lise Lotte Gluud
<p>SLD2025_Infographic_Final_SLJG</p>
<p>SLD2025_Infographic_Final_SLJG</p>
Keywords
MASH
Congress industry session
Semaglutide
PHASE 3 (RCT)